rediff.com
e.g. Tata motors, Reliance MF, 500570
SMS Pharmaceuticals Ltd. - Research Center
532815 SMSPHARMA Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Jun' 24 Mar' 24 Dec' 23 Sep' 23 Jun' 23
Sales 164.45 245.80 161.48 166.64 135.34
Operating profit 33.46 33.49 28.88 27.82 26.66
Interest 4.67 5.61 5.95 5.57 6.32
Gross profit 30.17 29.52 24.42 23.06 20.85
EPS (Rs) 1.93 1.88 1.44 1.42 1.10
Quarterly  results in details
Jun' 24 Mar' 24 Dec' 23 Sep' 23 Jun' 23
Other income 1.37 1.65 1.49 0.81 0.51
Stock adjustment -19.28 63.22 -41.22 -5.78 -17.22
Raw material 107.29 97.60 132.60 103.59 91.25
Power and fuel - - - - -
Employee expenses 16.88 20.12 14.02 13.65 13.55
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 26.09 31.36 27.21 27.36 21.10
Provisions made - - - - -
Depreciation 8.38 7.92 8.01 7.90 7.69
Taxation 5.46 5.69 4.24 3.11 3.87
Net profit / loss 16.33 15.92 12.17 12.05 9.28
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 8.47 8.47 8.47 8.47 8.47
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 20.35 13.62 17.88 16.70 19.70
GPM (%) 18.19 11.93 14.98 13.77 15.35
NPM (%) 9.85 6.43 7.47 7.19 6.83
Close
Add SMS Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add SMS Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close